|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Evanston Northwestern Healthcare, Evanston, IL.
Correspondence to: Daniel Ray MD, FCCP, Evanston Hospital, 2650 Ridge Ave, Evanston, IL 60201; e-mail: d-ray{at}nwu.edu
| Introduction |
|---|
|
|
|---|
A physical examination showed a well-developed man who was in considerable distress and was unable to get comfortable in the bed. Measurements of vital signs revealed the following: temperature, 102.5°F; pulse, 90 beats/min; respiratory rate, 20 breaths/min; BP, 110/69 mm Hg; and oxygen saturation, 97% on room air. A lung examination was remarkable for coarse breath sounds and crackles at both bases, greater on the right side than on the left. No cyanosis or clubbing was detected.
Laboratory findings were the following: WBC count, 16.1 cells/mm3; platelets, 362,000 cells/mm3. Sputum grew Streptococcus pneumoniae. The findings of a chest radiograph that was taken on hospital admission were normal. A CT scan of the abdomen made after hospital admission showed a small stone in the left proximal ureter and hydronephrosis. Repeat chest radiographs taken on the second day of admission (Figs 1 , 2 ) showed diffuse bilateral linear branching radiodensities that were greatest in the lower lungs. The patient underwent abdominal CT scans, which revealed high-density foci in the lungs, anterior right ventricle of the heart, apex of the left ventricle, liver, and kidney. Blood samples were taken.
|
|
| What is the diagnosis? |
|---|
|
|
|---|
| Discussion |
|---|
|
|
|---|
IV elemental mercury injection is infrequent, with reports scattered through the medical literature of accidental injections, suicide attempts, and iatrogenic injections from metallic mercury used as a anaerobic seal on blood gas-sampling syringes.3 There are even athletes who deliberately have given themselves IM and IV mercury injections in the false hope of developing strong musculature, or because the injection of "quicksilver" would result in faster punches.5 While neurologic or renal toxicity can occur, it is interesting that the majority of the patients described in the literature who have received IV mercury injections had relatively few toxicities despite sometimes massive doses (in one case, 20 mL elemental mercury5 ). Many of the short-term symptoms from IV injection can be attributed to pulmonary embolism and infarction from the mercury globules trapped in the pulmonary circulation. Chest pain, dyspnea, hypoxemia, and reversible pulmonary function defects are described.5 Death secondary to pulmonary infarction from mercury has been reported.6 Long-term, local tissue reactions to the mercury globules may lead to the formation of foreign-body granulomas. In experimental studies, miliary abscesses were found around mercury deposits in lung tissue in dogs,1 and an autopsy report on a patient known to have received long-term IV mercury injections noted similar findings.1
The metallic densities seen on a chest radiograph often can persist for years, showing only gradual resolution.7 Combined urinary, fecal, and expired air excretion of mercury is usually < 1 mg per day. Attempts at accelerated urinary excretion by the use of chelation agents can increase urinary rates threefold to fivefold. It is not clear that the use of these agents is warranted because of the extremely large doses achieved in IV injections and the relative paucity of toxic symptoms in many of these patients.7 The slow biological oxidation of metallic mercury may result in the formation of soluble salts, which ultimately are excreted by the colon, kidney, and salivary glands.7
In our patient, it was difficult to differentiate between the symptoms of respiratory distress found in pneumococcal infection and those in IV mercury injection. The patient received oxygen, IV antibiotic therapy, and, initially, dimercaprol (during BAL) as a chelation agent. Dimercaptosuccinic acid was substituted as a chelation agent to reduce toxicity, and the patients subsequent hospital course was notable for persistent fevers for 13 days, transient elevation in transaminase levels (possibly secondary to the dimercaptosuccinic acid therapy), and a Heinz body-positive hemolytic anemia secondary to glucose-6-phosphate dehydrogenase deficiency. The only toxicity directly attributable to the mercury was gingival stomatitis and periodontitis, which developed over several days following the mercury injection.
Received for publication March 28, 2001. Accepted for publication April 25, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Han, K. S. Lee, T. Franquet, N. L. Muller, T. S. Kim, H. Kim, O J. Kwon, and H. S. Byun Thrombotic and Nonthrombotic Pulmonary Arterial Embolism: Spectrum of Imaging Findings RadioGraphics, November 1, 2003; 23(6): 1521 - 1539. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |